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Snake venomIn the present study, an acidic PLA2, designated Bl-PLA2, was isolated from Bothrops leucurus snake venom
through two chromatographic steps: ion-exchange on CM-Sepharose and hydrophobic chromatography on
Phenyl-Sepharose. Bl-PLA2 was homogeneous on SDS-PAGE and when submitted to 2D electrophoresis the
molecular mass was 15,000 Da and pI was 5.4. Its N-terminal sequence revealed a high homology with other
Asp49 acidic PLA2s from snake venoms. Its speciﬁc activity was 159.9 U/mg and the indirect hemolytic activity
was also higher than that of the crude venom. Bl-PLA2 induced low myotoxic and edema activities as
compared to those of the crude venom. Moreover, the enzyme was able to induce increments in IL-12p40,
TNF-α, IL-1β and IL-6 levels and no variation of IL-8 and IL-10 in human PBMC stimulated in vitro, suggesting
that Bl-PLA2 induces proinﬂammatory cytokine production by human mononuclear cells. Bothrops leucurus
venom is still not extensively explored and knowledge of its components will contribute for a better
understanding of its action mechanism.Bothrops leucurus venom; CK,
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Phospholipase A2—PLA2 (EC 3.1.1.4)—is a class of enzymes that
catalyze the hydrolysis of sn-2-acyl bond of sn-3-phospholipids,
generating free fatty acids and lysophospholipids as products (van
Deenen and de Haas, 1963) and are currently classiﬁed in 15 groups on
the basis of disulphide bridge patterns, amino acid sequence similarity
and catalytic mechanisms (Schaloske and Dennis, 2006). Snake venom
PLA2s are known to belong to groups I (Elapidae/Hydrophidae) and II
(Viperidae/Crotalidae). The group II can be subdivided, subsequently, in
two main subgroups, depending on the residue at position 49 in the
primary structure: Asp49 (D49) are enzymatically active while Lys49
(K49) present lowor noenzymatic activity (Lomonte et al., 2003). There
are other subgroups, such as Asn49 (Tsai et al., 2004;Wei et al., 2006a),
Ser49 (Krizaj et al., 1991; Polgar et al., 1996); Gln49 (Bao et al., 2005)
and Arg49 (Chijiwa et al., 2006;Mebs et al., 2006;Wei et al., 2006b), butstudies have found that catalytic activity is reduced or even abolished
whenan aspartic acid of native phospholipasesA2 is replaced by another
amino acid (Li et al., 1994; Bao et al., 2005).
Snake venoms are rich sources of PLA2s and these enzymes
perform a variety of pharmacological and/or toxic effects, such as
myotoxicity, hemolysis, edema, anticoagulation, effects on platelet
aggregation, neurotoxicity, cardiotoxicity, hypotension, antitumoral
and antimicrobial activities (Gutiérrez and Lomonte, 1997; Ketelhut
et al., 2003; Stábeli et al., 2006; Rodrigues et al., 2007; Sami et al.,
2008). Moreover, local inﬂammation is a prominent characteristic of
snakebite envenomation by Viperidae and Crotalidae species (Dennis,
1994), due mainly to the presence of PLA2s and metalloproteinases
(Rucavado et al., 2002; Oliveira et al., 2009; Teixeira et al., 2009). The
pathogenesis of systemic effects in Bothrops envenomation is
complex, involving both the direct action of the venom components
on the tissue and the release of various endogenous mediators
(Petricevich et al., 2000). In literature, the action of both PLA2s Asp49
and Lys 49 in skeletal muscle cells disruption, as well as its role in
inﬂammatory reactions induction associated with edema, cellular
inﬁltration and pain have been widely demonstrated (Barros et al.,
1998; Petricevich et al., 2000; Carneiro et al., 2002; Chavez et al., 2005;
Zamuner et al. 2005; Zuliani et al., 2005; Bonﬁm et al., 2008; Teixeira
et al., 2009).
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in 1824 (BSH, 2010) and occupy the Northeast and Southeast regions
of Brazil, including Ceará, Bahia and Espírito Santo States (Porto and
Teixeira, 1995). This species has a large medical importance. An
epidemiological survey, conducted in Bahia State in 2001, reported
that in cases of conﬁrmed bothropic envenoming with the identiﬁ-
cation of the snake, all of them were attributed to B. leucurus (Mise
et al., 2007). Some components were isolated from this venom such as
three non-hemorrhagic metalloproteinases, leucurolysin-a (leuc-a)
(Bello et al., 2006), leucurolysin-B (leuc-B) (Sanchez et al., 2007) and
BleucMP (Gomes et al., 2011), a coagulant thrombin-like enzyme,
named leucurobin (leuc) (Magalhães et al., 2007), two L-amino acid
oxidase (Torres et al., 2010; Naumann, et al., 2011), two basic
phospholipases A2 designed blD-PLA2 and blK-PLA2 (Higuchi et al.,
2007) and a lectin (BIL) (Nunes et al., 2011).
The present article describes, for the ﬁrst time, the isolation
procedure and the biochemical characterization of a proinﬂammatory
acidic phospholipase A2 from B. leucurus venom, named Bl-PLA2.
2. Materials and methods
2.1. Materials
B. leucurus snake venom was obtained from Bioagents Serpentar-
ium (Batatais, SP, Brazil). CM-Sepharose, Phenyl-Sepharose CL-4B and
C18 column were purchased from GE Healthcare. Ethylenediaminete-
traacetic acid (EDTA), creatine kinase (CK-UV) kinetic kit, molecular
weight protein standards and acrylamide were obtained from Sigma
Chemical Co. The kits to cytokine measurement came from ELISA Set,
BD OptEIA™—Human (BD Biosciences). All other chemical reagents
were of analytical grade.
2.2. Animals and human blood
Swiss male mice were kindly provided by Vallée Institute (Minas
Gerais, Brazil) and maintained under standard conditions (tempera-
ture 22±1 °C, relative humidity 60±5%, 12 h light/dark cycle) with
diet and water ad libitum. The experimentation protocol was
approved by the Committee of Ethics for the Use of Animals from
Federal University of Uberlândia—Minas Gerais, Brazil (License
number 08-2008) and is in agreement with ethical principles of
animal experimentation adopted by the Brazilian Society of Science in
laboratory animals. Human blood was collected from volunteers and
approved by the Human Research Ethics Committees from Federal
University of Triângulo Mineiro, Brazil (CEP-UFTM) (License number
1079).
2.3. Isolation of the acidic phospholipase A2
Isolation of the acidic phospholipase A2 was carried out according
to Rodrigues et al. (2007), with some modiﬁcations. Samples of crude
venom (86.3 mg) were dispersed into 2.0 mL of 0.05 M ammonium
bicarbonate buffer, pH 7.8, cleared by centrifugation at 400×g for
10 min and applied on a CM-Sepharose fast ﬂow column (2.0×20 cm)
which was previously equilibrated and initially eluted with the same
buffer. A gradient was then applied up to 0.5 M buffer and fractions of
3 mL/tube were collected at a ﬂow rate of 20 mL/h. The fraction
showing PLA2 activity was lyophilized and then applied on a Phenyl-
Sepharose CL-4B column (1.0×10 cm) equilibrated with 0.01 M Tris–
HCl buffer plus 4 M NaCl, pH 8.5. Elution occurred at room
temperature, by decreasing concentrations of NaCl (4, 3, 2, 1 and
0.5 M) still in 0.01 M Tris–HCl buffer, pH 8.5, ending the elution
process with water.
The active fraction was applied on a reverse phase HPLC using a
C18 column of 2.0 × 2.5 cm (Shimadzu), which was equilibrated with
solvent A (0.1% triﬂuoroacetic acid and 5% acetonitrile) and elutedunder a concentration gradient of solvent B (60% acetonitrile, 0.1%
triﬂuoroacetic acid) from 0 to 60% at a ﬂow rate of 1 mL/min at room
temperature. The protein contents were monitored at 280 nm and the
single peak was separated and lyophilized to determine the N-
terminal sequence and biochemical properties. Proteins were esti-
mated by Bradford (1976).
2.4. Biochemical characterization
2.4.1. Electrophoresis
14% SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was per-
formed according to Laemmli (1970). Samples were heated at 100 °C for
5 min and then ran under reducing (SDS+10% β-mercaptoethanol)
conditions. The molecular mass markers used were: Bovine serum
albumin (66 kDa), ovalbumin (45 kDa), glyceraldehyde-3-phosphate
dehydrogenase (36 kDa), carbonic anhydrase (29 kDa), trypsinogen
(24 kDa), trypsin inhibitor (20.1 kDa),α-lactalbumin (14.4 kDa) (Amer-
sham Biosciences).
2.4.2. Two-dimensional electrophoresis
In order to determine the molecular mass and pI, Bl-PLA2 (25.0 μg)
was precipitated with 2-D Clean-up kit (GE Healthcare), according to
manufacturer's instructions. After drying, the precipitated was
solubilized in 200 μL of re-hydration buffer (6 M urea; 2 M thiourea;
2% ASB-14 (p/v); 15 mMDTT; 0.002% bromophenol blue 1%) plus 0.5%
(v/v) of IPG buffer, pH 3–10 (GE Healthcare). Re-hydration was
performed on IPGPhor III (GE Healthcare) system and took place
under voltage of 40 V for 14 h. We used polyacrylamide strips with
immobilized pH gradient (Immobiline DryStrip) at pH 3–10 range and
11 cm in length (GE Healthcare). After re-hydration, strips were
submitted to isoeletric focusing (IEF) on IPGPhor III, 34636 V/h.
After IEF, focused strips were incubated for 15 min in 10 mL of
equilibriumsolution (1.5 MTris–HCl pH8.8; 6 Murea; 30% v/v glycerol;
2% w/v SDS; 0.002% bromophenol blue 1% w/v) plus 10 mg/mL of DTT
(USB), followed by a second incubation in the same buffer, with the
inclusion of 25 mg/mL iodoacetomide (Sigma). Finally, strips were
subjected to electrophoresis on SDS-PAGE 8–18% (GEHealthcare) in the
Multiphor II system according to the program suggested by the
manufacturer's manual. Gels were stained with colloidal coomassie
blue (2% (w/v) coomassie G-250) for 72 h, destained in distilled water
and kept in ethanol 70% (v/v) until your digitalization in the scanner
Image Scanner (GEHealthcare), using the ImageMaster LabScan™ v 5.0
program (with 300 dpi resolution). Analyses were done visually and
also by the ImageMaster 2D Platinumv6.0 (GEHealthcare) program, as
recommended in themanual. The reference gel was obtained as a result
of biological triplicate analyses.
2.5. N-terminal sequence
Bl-PLA2 (1 mg) was dissolved in 0.25 M Tris–HCl buffer, pH 8.2,
containing 0.1% (w/v) EDTA. For each mole of Cys, 30 moles of
dithiothreitol were added. After being ﬂushed with N2, the solution
was incubated for 4 h at 50 °C in the dark. Excess vinylpyridine was
then added and incubation proceeded overnight. The reduced sample
was then puriﬁed on a C18 RP-HPLC column and its N-terminal
sequence was determined using a model PPSQ-23A Perkin-Elmer
Procise Sequenator (Applied Biosystem Division, Foster City, CA, USA)
with on-line identiﬁcation of the corresponding phenylthiohydantoin
derivatives. The N-terminal amino acid sequence of Bl-PLA2 was
aligned with sequences available in the Gene Bank and Swiss-Prot
databases using the Clustal program.
2.6. Enzymatic activity
PLA2 activity was assayed as described by de Haas and Postema
(1968). It was determined upon egg-yolk emulsion, which contains
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proteins. For the indirect hemolysis method, washed mice erythro-
cytes and hen's egg-yolk emulsion were used as substrate (Gutiérrez
et al., 1988). Each experiment was performed in triplicate and
independent assays were done.
2.7. Myotoxic activity
Groups of three Swiss male mice (18–22 g) were injected intramus-
cularly (i.m.) in the gastrocnemius muscle with 20 μg of crude venom
and 20 μg or 50 μg of Bl-LA2, dissolved in 50 μL of saline. The control
group received only 50 μL of saline. After 3 h, the bloodwas collected by
cardiac puncture in heparin-coated tubes and centrifuged at 320×g for
10 min at 4 °C for plasma separation. Activity of creatine kinase (CK) (EC
2.7.3.2)was thendeterminedusing10 μL plasma,whichwere incubated
for 3 min at 37 °C with 1 mL of the reagent, according to the Laborlab
Kinetic CK–UV protocol. Activity was expressed in U/L, one unit
resulting from the phosphorylation of 1 μmol of creatine/min at 25 °C.
Independent assays were done.
2.8. Edema-inducing activity
Groups of ﬁve Swiss male mice (18–22 g) were injected in the
subplantar region with the crude venom or Bl-PLA2 (20 μg/50 μL
saline). After 0.25, 0.5, 1, 2, 3, 6 and 24 h, the paw edema was
measured with the aid of a low-pressure spring caliper (Mitutoyo-
Japan) (Rodrigues et al., 2001). Zero time values were then subtracted
and the differences reported as mean±S.D. Independent assays were
done.
2.9. PBMC and cell culture
Peripheral blood mononuclear cells (PBMC) were obtained from
human whole blood donated by healthy volunteers, after centrifuga-
tion on a Ficoll-Paque Plus density gradient (GE Healthcare). PBMC
were cultivated in RPMI 1640 medium supplemented with 10% (v/v)
fetal bovine serum (FBS), 0.002 M L-glutamine, 0.002 M sodium
pyruvate, 0.001 M non-essential amino acids, 100 UI/mL penicillin,
100 μg/mL streptomycin, and incubated at 37 °C with 5% CO2, under
standard procedures. The cells were cultured at density of 1×106
cells/well in 24-well microplates. PBMC cell viability wasmeasured by
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay as described by Mosmann (1983) after treatment with
different doses of enzyme (2.5, 5 and 10 μg/well).
The PBMC were stimulated with crude venom or Bl-PLA2 at
different concentrations. Control PBMCs were cultured only in RPMI
medium. The cells were incubated at 37 °C for 24 h. After stimulation,
samples was centrifuged, the supernatants collected and stored at
−70 °C before cytokine assays.
2.10. Cytokine measurement
TNF-α, IL-8, IL-12p40, IL-10, IL-1β and IL-6 levels in supernatants
were measured by enzyme linked immunosorbent assay (ELISA),
according to the manufacturer's instructions. Cytokine concentrations
were then calculated by interpolation of the regression curve
corresponding to known amounts of recombinant cytokines provided
in the kit, and reported as pg/mL. Each experiment was done in
triplicate and independent assays were done. Detection limits
were: TNF-α, 1.4 pg/mL; IL-8, 0.6 pg/mL; IL-12p40, 1 pg/mL; IL-10,
1.2 pg/mL; IL-6, 4 pg/mL and IL-1β, 1.95 pg/mL.
2.11. Statistical analysis
The data were analyzed by Systat 10.2, BioStat5 and Statview
softwares. The results were expressed as means±standard deviation(S.D.). Statistic signiﬁcance of differences between groups was
evaluated by ANOVA or Kruskal–Wallis tests and conﬁrmed by
Tukey and Tukey-type tests. A p valueb0.05 was considered to
indicate statistically signiﬁcant difference.
3. Results and discussion
Acidic PLA2s have shown to be of high scientiﬁc interest due to
their abundance in venom and their several functions acquired during
evolution (Bonﬁm et al., 2008), such as bactericidal, antitumoral,
parasiticidal and pro- or anti-inﬂammatory effects (Rucavado et al.,
2002; Chacur et al., 2004; Rodrigues et al., 2004; Stábeli et al., 2006;
Costa et al., 2008; Cruz et al., 2008; Nevalainen et al., 2008; Sami et al.,
2008; Gebrim et al., 2009; Oliveira et al., 2009). Thus it becomes
relevant to isolate and study the clinical potential of these enzymes.
Fractionations of B. leucurus venom by ion-exchange chromatog-
raphy on CM-Sepharose column resulted in ﬁve major protein peaks
(Fig. 1A). BL1 fraction, showing high phospholipase A2 activity, was
further fractionated on Phenyl Sepharose CL-4B and resolved into two
new fractions, named BL1P1 and BL1P2 (Fig. 1B). BL1P2 was applied
on a HPLC reverse-phase chromatographic column and presented one
major peak, named Bl-PLA2 (Fig. 1C).
The puriﬁcation procedure according to Rodrigues et al. (2007)
showed to be also efﬁcient to isolate an acidic PLA2 from B. leucurus
snake venom, which corresponded to 5.4% of crude venom (Table 1),
high percentage when compared to approximately 4% obtained for
Bp-PLA2, after Phenyl Sepharose (Rodrigues et al., 2007) and 1.8% for
blD-PLA2, after all puriﬁcation procedure (Higuchi et al., 2007).
Homogeneity of Bl-PLA2 was further demonstrated by SDS-PAGE
(Fig. 1D). The puriﬁed protein consisted of a single polypeptide chain
with apparent approximate molecular weight of 15,000 and its pI was
5.4 (Fig. 1E).
The acidic PLA2 (Bl-PLA2) has an estimated molecular weight
ﬁtting with literature data which establish that snake venom PLA2s
present molecular weight varying between 13,000 and 18,000 (Ward
et al., 2001). Higuchi et al. (2007) isolated two basic phospholipases
A2 from B. leucurus snake venom with molecular weight for both of
14,000.
The ﬁrst sixty amino acids at the N-terminal sequence of Bl-PLA2
were determined (Fig. 2). As this protein contained Asp at position 48
(position 49 of the catalytic dyad, according to numbering of
Renetseder et al. (1985)), it was determined as an Asp49 PLA2. The
N-terminal sequence analysis of Bl-PLA2 showed that it contains all of
phospholipase A2 conserved residues involved in the calcium binding
and in the catalytic network (Tyr28, Gly30, Gly32, His48 and Asp49)
(Renetseder et al., 1985; Kudo and Murakami, 2002). N-terminal
sequences alignments of Bl-PLA2 with those of other bothropic Asp49-
PLA2s showed a high identity with acidic D49-PLA2s, highlighting
those from B. jararacussu (100%), B. pirajai (86%) and B. insularis
(81%). The lowest identity observed between Bl-PLA2 and acidic D49-
PLA2s was for B. moojeni (63%). On the other hand, alignments
between Bl-PLA2 and basic Asp49-PLA2s showed identities around
60%, one more strong evidence of acidic character of Bl-PLA2 (Fig. 2).
The speciﬁc PLA2 activity of Bl-PLA2 was 159.9±11.9 U/mg,
approximately two-folds higher than that of the crude venom (69.3
U/mg) (Table 1). Indirect hemolytic activity presented by Bl-PLA2 was
also higher than that of the crude venom (Table 1).
Bl-PLA2 induced low myotoxicity when compared with crude
venom (Table 2), regardless of enzyme concentration. Low or no
myotoxicity was also observed for four isoforms (SIIISPIIA, SIIISPIIB,
SIIISPIIIA and SIIISPIIIB) of acidic PLA2s isolated from B. jararacussu
(Ketelhut et al., 2003), BE-I-PLA2, an acidic D49 phospholipase A2
from B. erythromelas (Modesto et al., 2006), BaspPLA2-II, a basic D49-
PLA2 from B. asper (Fernández et al., 2010) and for an acidic PLA2, Ba
SpII RP4, isolated from B. alternatus (Denegri et al., 2010). In general,
acidic AspPLA2s are less myotoxic than basic PLA2s, although they are
Fig. 1. Sequential puriﬁcation steps of Bl-PLA2. (A) Bothrops leucurus venom (86.3 mg) on CM-Sepharose fast ﬂow, in 0.05 M ammonium bicarbonate buffer, pH 7.8. A gradient was
then applied up to 0.5 M buffer and fractions of 3 mL/tube were collected at a ﬂow rate of 20 mL/h. (B) Rechromatography of the active fraction, named BL1 (55 mg), on a column of
Phenyl–Sepharose CL-4B previously equilibrated with 10 mM Tris–HCl buffer, pH 8.5 plus 4 M NaCl at room temperature and then eluted with a decreasing concentration gradient
from 4 to 0 MNaCl plus 0.01 M Tris–HCl buffer, pH 8.5, ﬁnishing with water. (C) PLA2 isolation (Bl-PLA2) on a Shimadzu C18 reverse-phase high-performance liquid chromatography
(RP-HPLC) column. (D) SDS-PAGE (14%) of the puriﬁed PLA2. Lines: (PM)molecular weight marker, (1) reduced Bl-PLA2 (10 μg), (2) non-reduced Bl-PLA2 (10 μg). (E) Bidimensional
electhrophoresis: pI~5.4 for Bl-PLA2 was determined using the method previously described (see Methods section).
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pointed out to a myotoxic site in Lys49-PLA2 enzymes (residues 115–
116 to 129) constituted by combination of positively charged and
hydrophobic residues in C-terminal region, while non-myotoxic D49
PLA2s present, predominantly, neutral and negatively charged
surfaces, which do not permit the approach to negatively charged
membranes (Núñez et al., 2001; Chioato and Ward, 2003; Murakami
and Arni, 2003). Dos Santos et al. (2009) suggest that followingTable 1
Percent recoveries (% Rec.), phospholipase A2 and hemolytic activities along the puriﬁcatio
Sample Proteina Phospholipase A2 Activi
(U/mg)b
mg % Rec
CV 86.3 100 69.3±1.7
Step 1: CM-Sepharose (fraction BL1) 55 63.7 141.2±11.5d
Step 2: Phenyl Sepharose (fraction BL1P2) 4.7 5.4 158.7±11.9d
Purity assay: RP-HPLC (Bl-PLA2) 1.0f – 159.9±11.9d
a Bradford method (Bradford, 1976).
b PLA2 activity (de Haas and Postema, 1968).
c Indirect hemolytic activity (Gutiérrez et al., 1988) expressed in mm at different time in
d Statistically signiﬁcant difference (pb0.05) in relation to CV. (b) Statistically signiﬁcant
e Statistically signiﬁcant difference between BL1 and Bl-PLA2 (pb0.05).
f 1.0 mg of BL1P2 was applied on Schimadzu C18 column, just to evaluate the purity assaresidues Lys20, Lys115, Arg118 and Tyr119, conserved in all bothropic
Lys49-PLA2s, are important to myotoxic action and they would be
absent in Asp49-PLA2s. Moreover, dimer formation in myotoxic PLA2s
results in increase in the area of the positively charged surface, which
probably plays an important role in the recognition of the muscle
membranes and, consequently, in the expression of myotoxic activity
(Murakami and Arni, 2003). Finally, the lack of myotoxic activity may
be explained by the access to the active site of the enzyme is through an procedure of acidic PLA2 from B. leucurus crude venom (Bl-PLA2).
ty Hemolytic activity (mm)c
1 h 3 h 6 h 12 h 24 h
0 6.03±0.57 10.31±0.59 14.77±0.42 22.06±0.73
0 9,53±0,5d,e 14,27±0,05 d,e 19,12±0,71d,e 28.68±1.24d,e
0 9.96±0.4d 14.94±1.71d 20.77±0.63d 34,52±0.93d
0 10.95±0.6d,e 16.35±1.64d,e 21.03±1.19d,e 35.47±1.05d,e
tervals (n=3).
difference between BL1 and Bl-PLA2 (pb0.05).
y.
Fig. 2. Comparison of the N-terminal amino acid sequence of B. leucurus PLA2 (Bl-PLA2) with other bothropic Asp49-PLA2s. (A) Acidic D49-PLA2s: BthA-I-PLA2 from B. jararacussu
(GI: 56554156), Bpir PLA2-I from B. pirajai (GI: 258676481), BinTX-I from B. insulares (GI: 26006832), BaspPLA2-II from B. asper (GI: 292630844), BE-I-PLA2 from B. erythromelas
(GI: 86450426), Bpictus-PLA2 from B. pictus (GI: 9652397), Ba SPII RP4 from B. alternatus (GI: 292630845), Bp-PLA2 from B. pauloensis (Rodrigues et al., 2007), BmooTX-I from
B. moojeni (Santos-Filho et al., 2008). (B) Basic D49-PLA2s: BthTX-II from B. jararacussu (Pereira et al., 1998), BmTX-I from B. moojeni (GI:221272396), BnpTX-I e BnpTX-II from B.
neuwiedi (Rodrigues et al., 2004). Conserved residues involved in calcium binding (Tyr28, Gly30 and Gly32) and in catalytic network (His48 and Asp49) are marked.
230 D.C.O. Nunes et al. / Comparative Biochemistry and Physiology, Part C 154 (2011) 226–233narrow channel in the non-myotoxic Asp49 PLA2, meanwhile this
channel is much wider in myotoxic Lys49PLA2s (Murakami and Arni,
2003; Denegri et al., 2010).
Bl-PLA2 was able to induce maximum edema in 30 min, compared
with 1 h for the crude venom (Table 2). Several studies have
demonstrated that the edema onset and the time required to achieve
maximum levels vary considerably (Selistre et al., 1990), depending
on changes in composition and origin of venoms, as well as differences
in species of animals used as experimental model. The mechanism by
which catalytically active PLA2s induce edema may be explained by
phospholipid hydrolysis, probably due to liberation of precursors of
eicosanoids and platelet activator factors. Liberation of amines by
mast cells was proposed as a possible mechanism of edema induction
by PLA2s (Landucci et al., 2000). It is also important to note that the
catalytic activity has an important role, but it is not decisive in
edematogenic effect, that is, the phospholipases A2 may have a phar-Table 2
Myotoxic and edematogenic activities of crude venom from B. leucurus and Bl-PLA2.
Sample CK (U/mL)a Edema (%)b
0.25 h 0.5 h 1 h
Control 8.65±0.97 5.79±1.71 6.02±2.79 6.66±
CV 55.65±5.07 16.84±4.65 23.16±4.2 24.76
Bl-PLA2 (20 μg) 10.51±1.79c 9.16±2.26 11.92±3.28 4.06±
Bl-PLA2 (50 μg) 14.16±2.69c – – –
a 20 μg of CV and 20 or 50 μg of Bl-PLA2 were injected in the right gastrocnemius muscle
collected by cardiac puncture for later analysis of creatine kinase.
b 20 μg of CV or Bl-PLA2 were injected in the subplantar region of Swiss male mice (n=5)
2001).
c Statistically signiﬁcant difference (pb0.05) in relation to control and crude venom (CVmacological domain independent of the catalytic site (Kini and Evans,
1989; Bonﬁm et al., 2008), since some Lys49 PLA2s are able to induce
edema (Soares et al., 2000; Oliveira et al., 2009).
Cell viability analysis was carried out to verify whether Bl-PLA2
induces cytotoxic effects in the human PBMC. The cells were treated
with different doses (2.5, 5 and 10 μg Bl-PLA2/well) which were
shown to be non-cytotoxic (Fig. 3). PBMC cells were used, whereas in
previous studies it was found that PLA2s could recruit leukocytes
inﬁltration, mainly mononuclear cells, and that PLA2s could induce
such cells to release cytokines (Wei et al., 2006b). In this work, for the
ﬁrst time, we showed in vitro, the releasing proﬁle of some pro and
antiinﬂamatory cytokines by an acidic PLA2 from B. leucurus. As result,
we found that human PBMC stimulated in vitro with Bl-PLA2 showed
increments in IL-12p40, TNF-α, IL-1β and IL-6 levels in a dose-
dependentmanner, while no variation for IL-8 and IL-10were observed
(Fig. 4).2 h 3 h 6 h 24 h
2.66 1.78±0.9 1.1±0.64 0.2±0.1 0.2±0.1
±2.96 20.96±4.15 17.6±5.26 15.34±6.25 11.18±4.22
1.22 2.85±0.81 1.3±0.36 0.96±0.28 0.75±0.24
– – – –
of Swiss male mice (n=5). After 3 h, the animals were sacriﬁced and their blood was
. The increase of edema was measured after different intervals of time (Rodrigues et al.,
).
Fig. 3. MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] metabo-
lization by 2.0×105 peripheral blood mononuclear cells (PBMC) cultured in presence of
different concentrations of BI-PLA2 (2.5, 5.0 and 10.0 μg/mL) during 4 h at 37 °C/5% CO2.
231D.C.O. Nunes et al. / Comparative Biochemistry and Physiology, Part C 154 (2011) 226–233Inﬂammation is a major characteristic of envenomation by snakes
from Viperinae and Crotalinae species (Rosenfeld, 1971; Sawai, 1980).
Raised levels of proinﬂammatory cytokines have been detected in
the serum of human victims or in experimental models following
Bothrops and Crotalus envenoming (Barraviera et al., 1995; Barros
et al., 1998; Petricevich et al., 2000; Cardoso et al., 2001; CarneiroFig. 4. Cytokines levels on PBMC culture. The production of IL-8 (A), IL-12p40 (B), TNF-α
stimulated with different concentrations (2.5, 5 and 10 μg/well) of BlPLA2. The experiments w
and conﬁrmed by Tukey and Tukey-type tests. (a) Corresponds to pb0.05 between the exper
groups and control group.et al., 2002; Rucavado et al., 2002; Chavez et al., 2005; Cruz et al.,
2005; Zamuner et al., 2005; Zuliani et al., 2005; Cruz et al., 2008).
In their study,Wei et al. (2006b) showed that Promutoxin (Arg49),
a PLA2 isolated from Protobothrops mucrosquamatus, was also able to
evoke TNF, IL-6 and IL-1β releasing in a dose-dependent manner and
increased level of IL-12 in a concentration independent manner. We
also observed that BnSP-7, a basic Lys49 myotoxin isolated from
Bothrops (neuwiedi) pauloensis, was able to induce increments in
proinﬂammatory cytokines, such as IL-6 and IL-1 β, by skeletal muscle
cells (Oliveira et al., 2009). Another study testing two basic PLA2s
showed that both MT-II (catalytically inactive) and MT-III (catalyti-
cally active) induced increase in IL-1 and IL-6 levels in peritoneal ﬂuid
(Zuliani et al., 2005).
Mechanisms involved in the proinﬂammatory action of snake
venoms are being actively investigated and most of this knowledge is
based on studies using puriﬁed venom PLA2s. This action can result by
the different mechanisms such as enzymatic hydrolysis of phospho-
lipids through the direct release of arachidonic acid from the plasma
membrane; activation of intracellular processes in target cells (Zuliani
et al., 2005)or interactionofdistinctmolecular regions in the catalytic site
of Lys-49 PLA2 with cell membranes which induce cell activation leading
to an inﬂammatory reaction (Teixeira et al., 2003; Zuliani et al., 2005).(C), IL-10 (D), IL-1β (E) and IL-6 (F) by PBMC were assayed in supernatants of cells
ere performed in triplicate and analyzed statistically by ANOVA or Kruskal–Wallis tests
imental groups and control group. (b) Corresponds to pb0.01 between the experimental
232 D.C.O. Nunes et al. / Comparative Biochemistry and Physiology, Part C 154 (2011) 226–233Thus, Bl-PLA2, the newest acidic Asp 49 PLA2 from B. leucurus,
becomes a good target for study due to its inﬂammatory potential and
low cytotoxicity. A better understanding of PLA2 action mechanism in
inﬂammatory process could provide important clues to comprehend
the crude venom action and to develop novel therapeutic strategies to
treat snakebite envenomation.
4. Conclusion
Bl-PLA2, the acidic PLA2 from B. leucurus snake venom, was isolated
through two chromatographic steps, presenting an excellent purity
degree. It possesses an Asp at the site 49, and therefore being classiﬁed
as D49 PLA2. Bl-PLA2 did not show myotoxic activity, but induces
edema and secretion of some proinﬂammatory cytokines from highly
puriﬁed human monocytes, suggesting that it actively participates in
the pathogenesis of snake bite.
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